White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer’s Disease

Not recruiting

2 1
Investigated Diseases:
- Early onset familial Alzheimer’s disease
Investigated Drugs:
- Humanised Igg1 Monoclonal Antibody Against N-Terminally Truncated Pyroglutamate-3 Ab
- Florquinitau (18F)
Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn’s Disease Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
Study of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette’s Disorder

Not recruiting

3 1 1
Investigated Diseases:
- Tourette’s disorder
Investigated Drugs:
- Ecopipam Hydrochloride
+2
Study on Long-Acting Cabotegravir and Rilpivirine for HIV Patients in Spain: Evaluating Out-of-Hospital Treatment Options

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Not recruiting

3 1 1
Investigated Drugs:
+14
Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

Not recruiting

2 1
Investigated Diseases:
- Primary biliary cholangitis
Investigated Drugs:
- Volixibat
Study on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease

Not recruiting

2 1
Investigated Diseases:
- Systemic sclerosis pulmonary
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Vixarelimab
+2
Study on Octreotide for Patients with Symptomatic Polycystic Liver Disease

Not recruiting

4 1 1
Investigated Diseases:
- Polycystic liver disease
Investigated Drugs:
- Octreotide Hydrochloride
Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Not recruiting

3 1 1 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies